343 related articles for article (PubMed ID: 1346584)
21. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma.
Leonard JH; Cook AL; Nancarrow D; Hayward N; Van Gele M; Van Roy N; Speleman F
Cancer Detect Prev; 2000; 24(6):620-7. PubMed ID: 11198276
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
24. Multiple endocrine neoplasia: how many syndromes?
Schimke RN
Am J Med Genet; 1990 Nov; 37(3):375-83. PubMed ID: 1979712
[TBL] [Abstract][Full Text] [Related]
25. Allelotype of neuroblastoma.
Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma.
Tanaka N; Nishisho I; Yamamoto M; Miya A; Shin E; Karakawa K; Fujita S; Kobayashi T; Rouleau GA; Mori T
Genes Chromosomes Cancer; 1992 Nov; 5(4):399-403. PubMed ID: 1283329
[TBL] [Abstract][Full Text] [Related]
28. Two distinct regions involved in 1p deletion in human primary breast cancer.
Bièche I; Champème MH; Matifas F; Cropp CS; Callahan R; Lidereau R
Cancer Res; 1993 May; 53(9):1990-4. PubMed ID: 8097672
[TBL] [Abstract][Full Text] [Related]
29. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R
Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115
[TBL] [Abstract][Full Text] [Related]
30. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
[TBL] [Abstract][Full Text] [Related]
31. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
32. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
[TBL] [Abstract][Full Text] [Related]
34. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
[TBL] [Abstract][Full Text] [Related]
35. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
Radford DM; Ashley SW; Wells SA; Gerhard DS
Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
[TBL] [Abstract][Full Text] [Related]
37. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
38. Familial risk for neuroendocrine tumors.
Anderson RJ; Lynch HT
Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
[TBL] [Abstract][Full Text] [Related]
39. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
[TBL] [Abstract][Full Text] [Related]
40. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
Ebrahimi SA; Wang EH; Wu A; Schreck RR; Passaro E; Sawicki MP
Cancer Res; 1999 Jan; 59(2):311-5. PubMed ID: 9927038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
